Schwartz, G., Shee, K., Romo, B., Marotti, J., Kisselev, A., Lewis, L., & Miller, T. (2021). Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant. Oncologist.
Stile di citazione ChicagoSchwartz, Gary, Kevin Shee, Bianca Romo, Jonathan Marotti, Alexei Kisselev, Lionel Lewis, e Todd Miller. "Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing On Fulvestrant." Oncologist 2021.
Citazione MLASchwartz, Gary, et al. "Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing On Fulvestrant." Oncologist 2021.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.